BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32801636)

  • 1. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.
    Chen Y; Wang L; Luo S; Hu J; Huang X; Li PW; Zhang Y; Wu C; Tian BL
    Drug Des Devel Ther; 2020; 14():2945-2957. PubMed ID: 32801636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.
    Jian Y; Zhao M; Cao J; Fan T; Bu W; Yang Y; Li W; Zhang W; Qiao Y; Wang J; Wen A
    Drug Des Devel Ther; 2020; 14():2355-2370. PubMed ID: 32606603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
    Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
    Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization,
    Raikwar S; Yadav V; Jain S; Jain SK
    J Liposome Res; 2024 Jun; 34(2):239-263. PubMed ID: 37594466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
    Li T; Yu P; Chen Y; Sun B; Dong P; Zhu T; Meng X
    Eur J Med Chem; 2021 Oct; 222():113605. PubMed ID: 34126457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iRGD Co-Administration with Paclitaxel-Loaded PLGA Nanoparticles Enhance Targeting and Antitumor Effect in Colorectal Cancer Treatment.
    Li L; Yang M; Li R; Hu J; Yu L; Qian X
    Anticancer Agents Med Chem; 2021; 21(7):910-918. PubMed ID: 32698755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells.
    Yang T; Choi MK; Cui FD; Lee SJ; Chung SJ; Shim CK; Kim DD
    Pharm Res; 2007 Dec; 24(12):2402-11. PubMed ID: 17828616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs.
    Tang H; Xie Y; Zhu M; Jia J; Liu R; Shen Y; Zheng Y; Guo X; Miao D; Pei J
    Int J Nanomedicine; 2022; 17():3013-3041. PubMed ID: 35836838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes.
    Jiménez-López J; Bravo-Caparrós I; Cabeza L; Nieto FR; Ortiz R; Perazzoli G; Fernández-Segura E; Cañizares FJ; Baeyens JM; Melguizo C; Prados J
    Biomed Pharmacother; 2021 Jan; 133():111059. PubMed ID: 33378963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
    Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
    J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo.
    Biswas S; Dodwadkar NS; Deshpande PP; Torchilin VP
    J Control Release; 2012 May; 159(3):393-402. PubMed ID: 22286008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
    Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
    Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
    Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
    Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy.
    Shu X; Zhu Z; Cao D; Zheng L; Wang F; Pei H; Wen J; Yang J; Li D; Bai P; Tang M; Ye H; Peng A; Li W; Chen L
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110356. PubMed ID: 31319226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.